Methotrexate resistance in an in vivo mouse tumor due to a non-active-site dihydrofolate reductase mutation.

A series of methotrexate (MTX)-resistant L1210 leukemia murine ascites tumors were developed in vivo and analyzed for drug resistance. Three of 20 tumors studied expressed an altered dihydrofolate reductase (DHFR) and each was identical, having a C to T base transition at nucleotide 46 in the DHFR g...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dicker, A P, Waltham, M C, Volkenandt, M, Schweitzer, B I, Otter, G M, Schmid, F A, Sirotnak, F M, Bertino, J R
Formato: Artigo
Idioma:Inglês
Publicado em: 1993
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC48071/
https://ncbi.nlm.nih.gov/pubmed/8265628
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados